1 completed, 1 recruiting, 1 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Recruiting 1, Terminated 1 |
Follow Major Trauma: new trials by email Literature Review of Major Trauma trials Research Report on Major Trauma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients Epoetin Alfa 40000 UNT/ML, Sodium Chloride 0.9% - Trauma, Traumatic Injury | Phase 3 | Recruiting | Australian and New Zealand Intensive Care Research Centre | 2500 | 2020-11-09 | 2025-07-16 |
| Succinylcholine vs Rocuronium for Prehospital Emergency Intubation Succinylcholine : 1mg/kg, Rocuronium : 1.2 mg/kg - Coma, Major Trauma | Phase 3 | Completed | Centre Hospitalier Universitaire de la Réunion | 1321 | 2013-12-01 | 2017-12-15 |
| RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma Fibrinogen concentrate, Prothrombin complex concentrate and FXIII concentrate, Fresh Frozen Plasma blood type 0, A, B and AB - Major Trauma | Phase 3 | Terminated | Medical University Innsbruck | 100 | 2012-03-01 | 2016-03-23 |
Brain Injuries, Traumatic (1) · Coma (1) · Dyspnea (1) · Hemostatic Disorders (1) · Multiple Trauma (1) · Shock (1) · Signs and Symptoms (1) · Wounds and Injuries (1) · Wounds, Nonpenetrating (1) · Wounds, Penetrating (1)
Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Brain Diseases (1) · Brain Injuries (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Consciousness Disorders (1) · Craniocerebral Trauma (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pathologic Processes (1) · Respiration Disorders (1)
Epoetin Alfa (1) · Factor IX (1) · Fibrinogen (1) · Rocuronium (1) · Sodium Chloride (1) · Succinylcholine (1)
Australian and New Zealand Intensive Care Research Centre (1) · Centre Hospitalier Universitaire de la Réunion (1) · Medical University Innsbruck (1)
Australia (1) · Austria (1) · Belgium (1) · Finland (1) · France (1) · Germany (1) · Ireland (1) · New Zealand (1) · Saudi Arabia (1) · Slovenia (1) · Switzerland (1)
Associate Professor Craig French (1) · Professor Alistair Nichol (1) · Xavier Combes, MD (1)